Co-creation based approaches are transforming the way R&D and innovation is being conducted with interactive processes replacing linear processes
In Conversation
Yelda Ulu Colin – Managing Director Turkey, Iran, Azerbaijan, Georgia, Lebanon, N. Cyprus, Abbott Core Diagnostics

As a company, we were fortunate to be able to provide advanced healthcare IT systems [during the COVID-19 pandemic] that provided process optimization for users, helping…
Saudi Arabia is the heart of the Arab and Islamic world, an investment powerhouse and the hub connecting continents. Its geographic, cultural, social, demographic, and economic…
We, as Turkish Cargo, carry out our operations at top level by holding the "CEIV Pharma" certificate issued by IATA CEIV (Center of Excellence for Independent…
In Turkey NCDs account for 89 percent of all deaths with nearly one in five occurring in people under the age of 70-years
Turkey is an attractive investment destination due to its dynamic economy, young population and comprehensive national health system which covers most people living in Turkey, not…
I like the fact that Vision 2030 does not only focus on the localisation of products, but on the country’s human capital itself and the transfer…
The Kingdom of Saudi Arabia is a part of almost every discussion around Biogen’s future plans globally
Our advantage is due to unparalleled investment in biosimilar R&D and production; no other company in Turkey has invested as much as Arven
We have the potential to make significant contributions to Saudi’s Vision 2030 because of our extensive portfolio and capabilities in artificial intelligence (AI) and IT solutions…
That is the exciting part of MEA; the fact that you must think outside of the box to solve big issues
The [Turkish] government perceives plasma products as a strategically important product group and have developed a separate regulation and framework for them